Cargando…
The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease
BACKGROUND: The lower airways microbiome and host immune response in chronic pulmonary diseases are incompletely understood. We aimed to investigate possible microbiome characteristics and key antimicrobial peptides and proteins in idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonar...
Autores principales: | Knudsen, Kristel S., Lehmann, Sverre, Nielsen, Rune, Tangedal, Solveig, Haaland, Ingvild, Hiemstra, Pieter S., Eagan, Tomas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735599/ https://www.ncbi.nlm.nih.gov/pubmed/34990493 http://dx.doi.org/10.1371/journal.pone.0262082 |
Ejemplares similares
-
The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis
por: Knudsen, Kristel S., et al.
Publicado: (2022) -
Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
por: Tangedal, Solveig, et al.
Publicado: (2019) -
A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease
por: Martinsen, Einar M. H., et al.
Publicado: (2022) -
Protected sampling is preferable in bronchoscopic studies of the airway microbiome
por: Grønseth, Rune, et al.
Publicado: (2017) -
The pulmonary mycobiome—A study of subjects with and without chronic obstructive pulmonary disease
por: Martinsen, Einar M. H., et al.
Publicado: (2021)